Uncategorized

Organon Completes the Acquisition of Forendo Pharma, a Biotech Firm Focused on Women’s Health

Women’s Health Pharma company and Merck spin-off Organon, has completed its recently announced acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments in women’s health. Forendo’s lead candidate, FOR-6219, is an investigational, potentially first-in-class oral 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor entering Phase 2 clinical development for endometriosis. Forendo’s pipeline also includes a preclinical program targeting polycystic ovarian…

Hims & Hers Adds 10 New Members to its Medical Advisory Board

Hims & Hers, the multi-specialty telehealth platform, is expanding the size and scope of its Medical Advisory Board as it continues expanding more recent medical verticals such as mental health and primary care, and further growing early focus areas, such as sexual health, dermatology, and hair loss. The Medical Advisory board, which advises the company as it works to create access to…

Femtech Trendwatch: A Win for Femtech Advertising, Center of Intimacy Justice & Major Trends in Medicaid

You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.

Leading Accelerators DigitalHealth.London and Cedars-Sinai Partner to Support Healthtech Companies’ Internationalization Efforts

Leading accelerators programs DigitalHealth.London and the Cedars-Sinai Accelerator have announced a new partnership supporting international adoption of some of the US and UK’s best healthtech companies. The partnership will also utilize the deep healthcare knowledge and networks held by both organizations, to support companies who have taken part in either of the accelerator programs, to navigate and gain traction in a new…

Mayo Clinic’s Marani Health Raises $7.6M in Seed Funding for its Digital Platform for Prenatal and Postpartum Care

Marani Health, a digital prenatal and postpartum care solutions innovator co-founded by Mayo Clinic has announced the closing of a $7.6 million seed round. Participants in the round include strategic investor OneAlphaNorth Capital, who joins existing investors SWL Healthcare Ventures and TFX Capital as investors in this round. OneAlphaNorth Managing Director Brady Lipp is joining Marani’s board of directors. The new funding…